These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21493)

  • 21. [Immunosuppressive action of antithymocytic serum and specific antibodies on the formation of plaque- and rosette-forming cells].
    Korshunov VM; Pinegin BV
    Patol Fiziol Eksp Ter; 1974; (1):53-7. PubMed ID: 4617852
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity.
    Nehlsen SL
    Clin Exp Immunol; 1971 Jul; 9(1):63-77. PubMed ID: 4397709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
    [No Abstract]   [Full Text] [Related]  

  • 24. [Graft-versus-host reactions: models, susceptibility to control, and clinical analogies].
    Brune K
    Schweiz Med Wochenschr; 1970 Jan; 100(2):49-58. PubMed ID: 4400853
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of thymus lymphocytosis-stimulating substance on the activity of lymphoid cells in the "graft vs host" reaction].
    Malyzhev VA; Valueva TK; Davydova TI
    Fiziol Zh; 1977; 23(3):374-9. PubMed ID: 17554
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of manganese dichloride on the graft vs host activity of splenic lymphocytes in mice].
    Divanian Kh; Boshnakova E
    Eksp Med Morfol; 1988; 27(4):17-9. PubMed ID: 3266148
    [No Abstract]   [Full Text] [Related]  

  • 27. The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment.
    Okamoto I; Iwaki K; Koya-Miyata S; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Clin Immunol; 2002 May; 103(2):132-44. PubMed ID: 12027418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antilymphocyte serum (ALS) as immunosuppressive agent].
    Piardi W
    Folia Allergol (Roma); 1971; 18(1):27-68. PubMed ID: 4397372
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of Escherichia coli endotoxin on the graft-versus-host reaction in mice. 3. Runt disease in newborns.
    Skopińska E
    Arch Immunol Ther Exp (Warsz); 1974; 22(3):305-8. PubMed ID: 4151942
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of endotoxin of Escherichia coli on the graft-versus-host reaction in mice. II. Non-H-2 systems.
    Skopińska E
    Arch Immunol Ther Exp (Warsz); 1974; 22(3):301-4. PubMed ID: 4151941
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo induction of suppressor activity with rabbit antimouse thymocyte serum (ATS) and antigen.
    Simpson M; Tuttle S; Gozzo JJ
    Transplant Proc; 1977 Mar; 9(1):1041-4. PubMed ID: 325731
    [No Abstract]   [Full Text] [Related]  

  • 32. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical properties of mouse spleen cells involved in the mixed leukocyte reaction and graft-vs-host disease.
    el-Arini MO; Osoba D
    J Immunol; 1973 Jun; 110(6):1476-84. PubMed ID: 4145892
    [No Abstract]   [Full Text] [Related]  

  • 34. [Status of T- and B-lymphocytes in long living CBA--F1 (CBA X C57BL/6) chimeras].
    Cherniakhovskaia IIu; Nesterenko VG; Filitis LN; Fontalin LN; Novikova TK
    Biull Eksp Biol Med; 1978 Aug; 86(8):197-200. PubMed ID: 28802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of hematopoiesis after treatment with antithymocyte serum and erythropoietin.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1974; 2(4):204-11. PubMed ID: 4616844
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell-mediated immunity and aging.
    Stutman O
    Fed Proc; 1974 Sep; 33(9):2028-32. PubMed ID: 4153574
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 38. Malononitrilamides inhibit the development of various murine graft-vs-host diseases.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3043-7. PubMed ID: 8962181
    [No Abstract]   [Full Text] [Related]  

  • 39. Possibility of three distinct and separable components to fatal graft-vs-host reaction.
    Okunewick JP; Meredith RF; Raikow RB; Buffo MJ; Jones DL
    Exp Hematol; 1982 Mar; 10(3):277-91. PubMed ID: 7040093
    [No Abstract]   [Full Text] [Related]  

  • 40. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.